Quetiapine N-oxide–fumaric acid (2/1)
نویسندگان
چکیده
منابع مشابه
Quetiapine N-oxide–fumaric acid (2/1)
THE TITLE COMPOUND (SYSTEMATIC NAME 2-{2-[4-(dibenzo[b,f][1,4]thia-zepin-11-yl)piperazin-1-yl 1-oxide]eth-oxy}ethanol-fumaric acid (2/1)), C(21)H(25)N(3)O(3)S·0.5C(4)H(4)O(4), is one of the oxidation products of quetiapine hemifumaric acid. In the tricyclic fragment, the central thia-zepine ring displays a boat conformation and the benzene rings are inclined to each other at a dihedral angle of...
متن کامل21 N Arrative a Nalysis
Key points 21.1 Introduction 21.2 What is narrative analysis? 21.2.1 The traditional status of qualitative data 21.2.2 Narrative analysis 21.2.3 Definitions 21.2.4 Example: narratives of chronic illness 21.2.5 Example: stories of homelessness 21.3 The social production of the story 21.3.1 Stories as symbolic interactions 21.3.2 Stories as political process 21.3.3 Representation 21.4 Using a nar...
متن کامل3α-Hydroxytirucalla-8,24-dien-21-oic acid
The title compound, C(30)H(48)O(3), a triterpene isolated from the resin of canarium schweinfurthiiand, is an isomer of the previously reported triterpene 3α-hy-droxy-tirucalla-7,24-dien-21-oic acid [Mora et al. (2001 ▶). Acta Cryst. C57, 638-640], which crystallizes in the same trigonal space group. The title mol-ecule consists of four fused rings having chair, half-chair, half-chair and envel...
متن کاملPhthalimide-N-sulfonic acid and Isatin-N-sulfonic acid as highly efficient catalysts for the synthesis of bis-coumarins
Two highly efficient protocols for the production of bis-coumarins under solvent-free conditions have been introduced. The reaction of 4-hydroxycoumarin (2 eq.) with arylaldehydes (1 eq.) using phthalimide-N-sulfonic acid (PhtSA) or isatin-N-sulfonic acid (IsSA), as solid-acid catalysts, afforded the mentioned compounds with good to excellent yields in short times.Briefly, we have introduced tw...
متن کاملRhabdomyolysis secondary to quetiapine.
Quetiapine is one of the drugs used most in current Psychiatry due to its therapeutic efficiency and clinical safety. We report the case of a 26-year-old male patient with severe mental retardation due to Y-chromosome partial deletion who initiated treatment with quetiapine for the control of his aggressiveness, and who developed severe rhabdomyolysis two weeks later. In spite of the confirmed ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Crystallographica Section E Structure Reports Online
سال: 2012
ISSN: 1600-5368
DOI: 10.1107/s1600536812020818